BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 25573965)

  • 1. Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M.
    Miyata M; Lee JY; Susuki-Miyata S; Wang WY; Xu H; Kai H; Kobayashi KS; Flavell RA; Li JD
    Nat Commun; 2015 Jan; 6():6062. PubMed ID: 25585690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current challenges in clinical development of "targeted therapies": the case of acute myeloid leukemia.
    Estey E; Levine RL; Löwenberg B
    Blood; 2015 Apr; 125(16):2461-6. PubMed ID: 25762181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia.
    Dang J; Wei L; de Ridder J; Su X; Rust AG; Roberts KG; Payne-Turner D; Cheng J; Ma J; Qu C; Wu G; Song G; Huether RG; Schulman B; Janke L; Zhang J; Downing JR; van der Weyden L; Adams DJ; Mullighan CG
    Blood; 2015 Jun; 125(23):3609-17. PubMed ID: 25855603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptor function and resilience: a tale of mice and men.
    McClung CA
    Biol Psychiatry; 2015 Feb; 77(4):310-1. PubMed ID: 25592268
    [No Abstract]   [Full Text] [Related]  

  • 5. Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia.
    Mallampati S; Leng X; Ma H; Zeng J; Li J; Wang H; Lin K; Lu Y; Yang Y; Sun B; Gong Y; Lee JS; Konopleva M; Andreeff M; Arlinghaus RB; Cai Z; Fang B; Shen H; Han X; Hirsch-Ginsberg CF; Gao X; Paranjape AN; Mani SA; Clise-Dwyer K; Sun X
    Blood; 2015 May; 125(19):2968-73. PubMed ID: 25712988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia].
    Xu JY; Luo JM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Aug; 19(8):945-949. PubMed ID: 28774373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel BIM deletion polymorphism: implications and lessons for cancer targeted therapies.
    Soh S; Ong ST
    Rinsho Ketsueki; 2013 Oct; 54(10):1714-9. PubMed ID: 24064821
    [No Abstract]   [Full Text] [Related]  

  • 8. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
    Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
    Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia.
    Bachmann PS; Gorman R; Papa RA; Bardell JE; Ford J; Kees UR; Marshall GM; Lock RB
    Cancer Res; 2007 May; 67(9):4482-90. PubMed ID: 17483364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
    Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
    Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia.
    Soh SX; Lim JY; Huang JW; Jiang N; Yeoh AE; Ong ST
    PLoS One; 2014; 9(8):e103435. PubMed ID: 25090024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.
    Gagné V; Rousseau J; Labuda M; Sharif-Askari B; Brukner I; Laverdière C; Ceppi F; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Krajinovic M
    Clin Cancer Res; 2013 Sep; 19(18):5240-9. PubMed ID: 23908358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin and yang of glucocorticoid receptors in apoptosis.
    Horton T
    Blood; 2015 Jan; 125(2):209-11. PubMed ID: 25573965
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.